EUVIMEDEUVIMED entdecken
FallberichtOpen Access

A Case of Combined Small-cell Carcinoma and Adenocarcinoma of the Lung With EGFR Exon 19 Deletion Identified via Liquid Genomic Profiling

Yohei Fukuda, Kosuke Hashimoto, Kyoichi Kaira, Atsuto Mouri, Reina Ishii, Naohito Hashimoto, Y U Miura, Ayako Shiono, O U Yamaguchi, Hisao Imai, Hiroshi Kagamu

In Vivo · 2025

DOI: 10.21873/invivo.14164 ↗

Kurz gefasst

Fallbericht in der Zeitschrift In Vivo, 2025. Verfasst von Yohei Fukuda und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Training Center, International Medical Center, Saitama Medical University, Saitama, Japan. Hauptthemen laut MEDLINE: Exons, Adenocarcinoma of Lung, Lung Neoplasms, Small Cell Lung Carcinoma. Der Volltext ist frei in PubMed Central verfügbar.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND/AIM: Mixed histological lung cancers, such as combined small-cell carcinoma (SCLC) and adenocarcinoma, are rare and often present diagnostic and therapeutic challenges due to intratumoral heterogeneity. In such cases, conventional tissue biopsies may fail to detect key genetic alterations, especially when sampling is limited or affected by tumor evolution. Liquid biopsy has emerged as a complementary approach capable of capturing broader genomic information in a non-invasive manner. CASE REPORT: We describe a 73-year-old woman with metastatic lung cancer initially diagnosed as EGFR wild-type adenocarcinoma via tissue biopsy. The patient underwent multiple lines of therapy, including immune checkpoint inhibitors and cytotoxic chemotherapy. Over time, the histology shifted, and repeat biopsy identified small-cell carcinoma. Due to the tumor's evolving nature and limited biopsy accessibility, a liquid biopsy using FoundationOne Liquid CDx was performed. This identified an EGFR exon 19 deletion (T751_A755del) that had not been detected in prior tissue analyses. Targeted therapy with osimertinib was initiated as fifth-line treatment, resulting in temporary disease stabilization and reduction in tumor markers. CONCLUSION: This case illustrates the clinical value of liquid biopsy in detecting actionable mutations in patients with mixed histological lung cancers where tissue-based testing is inconclusive. Liquid biopsy enabled a personalized therapeutic approach without the need for further invasive procedures. Such strategies may be essential in managing histologically and genomically heterogeneous tumors.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

ExonsAdenocarcinoma of LungLung NeoplasmsSmall Cell Lung CarcinomaSequence DeletionHumansFemaleAgedErbB ReceptorsLiquid BiopsyBiomarkers, TumorGenomicsAcrylamidesAniline CompoundsIndolesPyrimidines

Stichwörter der Autor:innen

Combined small-cell carcinoma and adenocarcinomaEGFRFoundationOne Liquid CDxliquid biopsy

Substanzen

ErbB ReceptorsEGFR protein, humanBiomarkers, TumorosimertinibAcrylamidesAniline CompoundsIndolesPyrimidines

Autor:innen und Institutionen

  • Department of Clinical Training Center, International Medical Center, Saitama Medical University, Saitama, Japan.
  • Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Saitama, Japan.
  • Department of Respiratory Medicine, International Medical Center, Saitama Medical University, Saitama, Japan hkosuke@saitama-med.ac.jp.

Zitieren

APA

Fukuda, Y., Hashimoto, K., Kaira, K., Mouri, A., Ishii, R., Hashimoto, N., Miura, Y. U., Shiono, A., Yamaguchi, O. U., Imai, H., & Kagamu, H. (2025). A Case of Combined Small-cell Carcinoma and Adenocarcinoma of the Lung With EGFR Exon 19 Deletion Identified via Liquid Genomic Profiling. In Vivo. https://doi.org/10.21873/invivo.14164

Vancouver

Fukuda Y, Hashimoto K, Kaira K, Mouri A, Ishii R, Hashimoto N, et al. A Case of Combined Small-cell Carcinoma and Adenocarcinoma of the Lung With EGFR Exon 19 Deletion Identified via Liquid Genomic Profiling. In Vivo. 2025. doi:10.21873/invivo.14164

BibTeX
@article{Fukuda2025,
  author = {Fukuda, Yohei and Hashimoto, Kosuke and Kaira, Kyoichi and Mouri, Atsuto and Ishii, Reina and Hashimoto, Naohito and Miura, Y U and Shiono, Ayako and Yamaguchi, O U and Imai, Hisao and Kagamu, Hiroshi},
  title = {A Case of Combined Small-cell Carcinoma and Adenocarcinoma of the Lung With EGFR Exon 19 Deletion Identified via Liquid Genomic Profiling},
  journal = {In Vivo},
  year = {2025},
  doi = {10.21873/invivo.14164}
}
Kostenlos starten →